跳至主要内容
临床试验/NCT05061238
NCT05061238进行中(未招募)不适用

Impact Of Muscle Vibration On Gait Control

M.D. Anderson Cancer Center2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2021年10月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
15
试验地点
2
主要终点
To establish the effect of a vibrating device applied to selected muscles on the step times of adolescent or young adult (AYA).

研究概览

简要总结

This is a single-site interventional open label pilot study of a non-significant risk medical device on patients with defined peripheral neuropathy secondary to chemotherapy (N=10). Patients who have received chemotherapy and have evidence of neuropathy will be seen at MD Anderson. Their severity of neuropathy will be documented and assessed by physical therapy, occupational therapy and based on self-reported activities of daily living (ADL) impairment.

详细描述

Primary Objective:

To assess the effect of a vibrating device applied to selected muscles on the step

Secondary Objectives:

  • To summarize the adverse events of different levels from using the vibrator device in oncologic AYA patients visiting the outpatient clinic.
  • To summarize the irritation, pain, and sensation of the application of vibration by the AYA patients, as determined by the survey during the application

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
6 Years 至 39 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects between the ages of 6 and 39 years.
  • Study subjects, or their parent/legal guardian for subjects <18 years, must be able to understand the purpose and risks of the study and to provide signed and dated informed consent and authorization to use confidential health information in accordance with national and local subject privacy regulations.
  • History of any type of cancer-
  • Diagnosed with peripheral neuropathy-associated gait dysfunction as defined by the treating physician.
  • Able (in the Investigators estimation) and willing to comply with all study requirements.
  • Subjects must be able to walk; assistance of a walker or similar support apparatus is allowed.
  • Patients with ankle foot orthosis (AFOs) are allowed but will need to be removed prior to testing.

排除标准

  • Participants with amputations, prosthetics, congenital malformations or any severe lower extremity deformities affecting gait before trials.
  • Abnormalities of the lower extremities as determined by the investigator.
  • Unstable participants or participants with hypotension (systolic blood pressure <90 and diastolic blood pressure < 60mmHg).
  • Any other significant disease or disorder which, in the opinion of the investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.
  • Other unspecified reasons that, in the opinion of the Investigator make the subject unsuitable for enrolment
  • Pregnant women
  • Children <15 years old

研究组 & 干预措施

Vibrating Device

Other

you will be asked to walk up and down a hallway 5 times with the vibrating device strapped to different parts of your leg.

干预措施: Vibrating Device (Device)

结局指标

主要结局

To establish the effect of a vibrating device applied to selected muscles on the step times of adolescent or young adult (AYA).

时间窗: through study completion, an average of 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验